Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) also known as Liver cancer is a primary malignancy disorder of the liver occurring primarily in patients with chronic hepatitis and other liver diseases. Hepatocellular carcinoma is the 3rd major leading cause of cancer-related deaths globally. The common symptoms are yellowish skin, severe abdominal swelling and pain, loss of appetite, weight loss, nausea, vomiting, and fatigue. People with chronic Hepatitis B and/ hepatitis C, patients with history of alcohol abuse, presence of aflatoxins, people with hemochromatosis, or with non-alcoholic steatohepatitis, type 2 diabetes, Wilson’s diseases, and Hemophilia, are at high risk of liver cancer. Treatment methods include surgical re-section, where surgeons remove the part of the liver having tumor while trying to preserve the healthy liver tissue. This method is not always desirable because only about 15% people globally are eligible for resection. Other most common treatment method is liver transplant. But, owing to the shortage of the organ with increasing list of patients for transplant, this option is not always recommended. The most common therapies prescribed by doctors are the Ablative therapies, viz., radiofrequency ablation (RFA), Cryo-ablation, Per-cutaneous ethanol injection, portal vein embolization, and potentially novel chemotherapeutic agents. These therapies help the patients in relieving the symptoms and provide relief. 

  • Liver diseases
  • Liver cirrhosis
  • Diabetes mellitus
  • Hepatic Screening and Imaging
  • Hepatic Pathology
  • Hepatic resection
  • Liver transplantation
  • Ablation therapies
  • Portal Vein Embolization

Related Conference of Hepatocellular Carcinoma

June 28-30 2020

chemistry 2020

June 28-30 2020

nursingeducation 2020

March 18-19, 2020

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
March 18-19, 2020

11th International conference on Liver and Hepatitis

Amsterdam, Netherlands
March 30-31, 2020

7th International Conference on Hepatology

Osaka, Japan
June 28-30 2020

biotec asia pacific 2020

June 28-30 2020


June 28-30 2020


June 20-21, 2020

euro health 2020

Tokyo, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome, Italy
July 20-21, 2020

20th World Gastroenterologists Summit

Osaka, Japan
June 28-30 2020

naturalproductssummit 2020

September 28-29. 2020

3rd World Liver Congress

Abu Dhabi, UAE
November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
November 23-24, 2020

World Conference on Digestive and metabolic Diseases

Hanoi, Vietnam
December 07-08 , 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzeland

Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in